|
|
Article: St. Jude Medical Announces U.S. Commercial Release of Pacesetter Trilogy DR+ Pacemaker
- Article from:
- PR Newswire
- Article date:
- October 1, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Automatic and Intelligent Technology Including Auto Mode Switching is
Designed to Promote Improved Clinical and Economic Outcomes
ST. PAUL, Minn., Oct. 1 /PRNewswire/ -- St. Jude Medical, Inc. (Nasdaq-NNM: STJM) announced today U.S. commercial release of the Trilogy(TM) DR+ pacemaker developed by its cardiac rhythm management business, Pacesetter, a world leader in innovative pacing technology. The device incorporates auto mode switching. Pacesetter, located in Los Angeles, Calif., received U.S. Food and Drug Administration (FDA) approval of the device yesterday.
The first pacing system to offer true "automaticity," the ...